OGI.V - OrganiGram Holdings Inc.

TSXV - TSXV Delayed Price. Currency in CAD
5.33
+0.09 (+1.72%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close5.24
Open5.38
Bid5.33 x 0
Ask5.35 x 0
Day's Range5.24 - 5.55
52 Week Range2.13 - 5.93
Volume1,392,141
Avg. Volume751,325
Market Cap665.04M
Beta5.82
PE Ratio (TTM)1,776.67
EPS (TTM)0.00
Earnings DateJul 27, 2017 - Jul 28, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.09
  • Benzinga5 hours ago

    Cannabis Companies Strike Supply Agreements In Ontario: What Does It Mean?

    The Ontario Cannabis Store, the province’s sole legal provider of cannabis, announced a partnership with 26 licensed producers for its online retail platform. The "420 Investor" Alan Brochstein commented on this announcement during an appearance on Benzinga's PreMarket Prep trading show. “Ontario is the largest province by far in Canada and there was a distribution system that was set up initially that was going to be very challenging," Brochstein said Tuesday morning.

  • Reuters10 hours ago

    Canada's Ontario signs online supply deals for recreational marijuana

    Ontario, Canada's biggest province, has signed agreements with 26 cannabis producers including Canopy Growth Corp, Aurora Cannabis Inc and Aphria Inc to supply products when it begins online sales of recreational marijuana in October. The selected companies, which also include Hydropothecary Corp, Tilray Canada Inc, and CannTrust Holdings Inc, will supply the province with dried flower, cannabis oil and cannabis seeds, the provincial government said in an emailed statement late Monday.

  • CNW Group13 hours ago

    Organigram becomes an official cannabis supplier to the Province of Ontario, Canada's largest adult recreational market

    MONCTON, NB , Aug. 21, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce that it has been approved as a supplier of cannabis for the province of Ontario . Under the terms of the agreement with Ontario Cannabis Retail Corporation (OCRC), Organigram will provide the Province with 27 SKUs of products including dried flower, pre-rolled product, cannabis oils and the premium offering of the Edison Reserve brand.

  • ACCESSWIRE11 days ago

    Today's Research Reports on Emblem, OrganiGram Holdings, Oncolytics Biotech and Aptose Biosciences

    NEW YORK, NY / ACCESSWIRE / August 10, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group20 days ago

    Mount Allison receives support from Organigram Inc. and NB Regional Development Corporation to support cannabis harms reduction education programming and initiatives

    MONCTON, NB , Aug. 1, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF), the parent company of Organigram Inc., a leading  licensed producer of medical marijuana and the New Brunswick Regional Development Corporation (RDC) will provide funding to Mount Allison to support the University's efforts to ensure the new legislation is fully communicated on campus, and to implement appropriate harms reduction initiatives established by the University. In preparation for the legalization of cannabis on October 17 , the University developed a working group earlier this year made up of students (including representatives from the Mount Allison Students Union), and staff.

  • CNW Group23 days ago

    Organigram Announces Record Q3 Financial Results - Net Income of $2.8 Million for the Quarter

    Organigram Announces Record Q3 Financial Results - Net Income of $2.8 Million for the Quarter

  • ACCESSWIRE27 days ago

    Canadian Exchanges Stock Scanner IMV Inc, IntelliPharmaCeutics International, OrganiGram Holdings, and Antibe Therapeutics

    LONDON, UK / ACCESSWIRE / July 25, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equitiesfrom the Biotechnology industry: IMV Inc., IntelliPharmaCeutics International, OrganiGram Holdings, and Antibe Therapeutics. The TSX Venture Exchange shaved off 3.89 points, or 0.55%, to finish at 706.42. Today's stocks of interest consist of: IMV Inc. (TSX: IMV), IntelliPharmaCeutics International Inc. (TSX: IPCI), OrganiGram Holdings Inc. (TSX-V: OGI), and Antibe Therapeutics Inc. (TSX-V: ATE).

  • CNW Grouplast month

    Organigram Provides Expansion Update as Phase 4 Construction Begins

    MONCTON, NB , July 23, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is in the final stages of planting the remaining three of the sixteen three-tier Phase 3 cultivation rooms which have been licensed by Health Canada. In total, the Company's Phase 3 expansion has increased Organigram's target dried flower equivalent production capacity from an estimated 22,000 kg/annum (Phases 1 and 2) to 36,000 kg/annum (Phases 1, 2 and 3).

  • ACCESSWIRElast month

    Today's Research Reports on Emblem, OrganiGram, Oncolytics Biotech and Aptose Biosciences

    NEW YORK, NY / ACCESSWIRE / July 11, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Grouplast month

    Organigram Signs Strategic Supplier Agreement with Hiku Brands

    MONCTON, NB , July 10, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce that it has entered into a letter of intent ("LOI") with Hiku Brands Company Ltd. (CSE:HIKU) ("Hiku").

  • CNW Group2 months ago

    Organigram signs supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC)

    MONCTON, NB, July 5, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading  licensed producer of medical marijuana, is pleased to announce that the Company has signed a supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC) in anticipation of the launch of a legal, adult use recreational cannabis market in the Province of Alberta .

  • Reuters2 months ago

    Energy and pot stocks help TSX to best quarter in 4 years

    Canada's main stock index notched its biggest quarterly gain in more than four years and could gain more this year as higher oil prices boost energy shares and legalization of pot leads to deal making among cannabis companies, investors said. In the second quarter, the TSX was led by a 16 percent jump for the energy sector, which accounts for about one-fifth of the weight of the index. Smaller, growth-orientated sectors, such as technology and healthcare also contributed, with the latter boosted by the strong performance of cannabis stocks.

  • CNW Group2 months ago

    Organigram signs supply agreement with Manitoba Liquor & Lotteries

    MONCTON, NB , June 29, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that it has been approved as a supplier of cannabis for the province of Manitoba . "We are proud to work with MBLL to offer residents of Manitoba a choice of high-quality cannabis products," says Tim Emberg , Organigram Vice President of Sales and Commercial Operations.

  • CNW Group2 months ago

    Orgranigram applauds Senate vote in support of Bill C-45

    MONCTON, NB , June 8, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased that Bill C-45 has been passed by the Senate in a historic vote, clearing another key milestone on the way to the legalization of adult-use recreational cannabis in Canada . "As a company, we are pleased to see Bill C-45 continue to make its way through the regulatory process," says Greg Engel , CEO, Organigram.

  • CNW Group3 months ago

    Organigram Announces Health Canada Licensing of Phase 3 Cultivation Expansion

    TORONTO , June 5, 2018 /CNW/ - Organigram Holdings Inc. ("Organigram" or the "Company") (TSX VENTURE: OGI) (OGRMF) a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that it has received an expanded cultivation license from Health Canada related to its previously announced Phase 3 expansion. The remaining ten Phase 3 rooms are expected to come online on or before June 30, 2018 in stages pending Health Canada approval.

  • FSCWire3 months ago

    Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation

    Organigram Holdings Inc. (“Organigram”) (TSX VENTURE: OGI) (OTCQB: OGRMF) and Eviana Health Corporation (“Eviana”) (CSE: EHC) (OTC: EVNNF) (collectively the “Companies”) are pleased to jointly announce that the Companies have entered into a non-binding term sheet (the “Term Sheet”) whereby Organigram will make a significant equity investment into Eviana.  Additionally, the Term Sheet contemplates Organigram entering into an offtake agreement with Eviana for up to 50% of the cannabidiol (“CBD”) production of Eviana for a period of five years, subject to adjustment based on Organigram’s equity interest in Eviana. “This agreement is a key facet of our ongoing international expansion efforts,” explains Greg Engel, CEO, Organigram.

  • ACCESSWIRE3 months ago

    Today's Research Reports on Centric Health, Emblem, OrganiGram and Acerus Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / June 4, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...

  • CNW Group3 months ago

    Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.

    MONCTON, NB , May 24, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF) ("Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that it has entered into a letter of intent with Hyasynth Biologicals, Inc. ("Hyasynth") whereby Organigram proposes to make a strategic investment in Hyasynth.  Additionally, the non-binding letter of intent contemplates Organigram entering into an off-take agreement with Hyasynth whereby Organigram can purchase a pre-defined quantity of a range of cannabinoids or cannabinoid related production from Hyasynth on terms set forth in such agreement.

  • CNW Group3 months ago

    Organigram Receives Permit to Export Medical Cannabis to Australia

    Organigram Receives Permit to Export Medical Cannabis to Australia

  • CNW Group3 months ago

    Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada

    MONCTON, NB , May 15, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that Health Canada has issued the Company a License for Controlled Drugs and Substances ("Dealer's License") making Organigram a "Licensed Dealer".

  • Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
    CNW Group3 months ago

    Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands

    Organigram's unprecedented recreational portfolio will be officially launched once adult use recreational cannabis is legal in Canada and includes the launch of The Edison Cannabis Company, ANKR Organics and Trailer Park Buds.

  • CNW Group3 months ago

    Organigram Announces First International Expansion Investment

    MONCTON, NB , May 8, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce it has entered a non-binding term sheet to acquire up to 25 per cent of alpha-cannabis Pharma GmbH ("Alpha-Cannabis Germany" or "ACG") located in Stadthagen, Germany .

  • CNW Group4 months ago

    Organigram Announces Record Q2 Financial Results - Net Income of $1.1 Million

    Organigram Announces Record Q2 Financial Results - Net Income of $1.1 Million

  • CNW Group4 months ago

    Organigram Begins First Harvests From New Grow Rooms

    Organigram Begins First Harvests From New Grow Rooms

  • Cannabis Growth Opportunity Corporation announces investment in US based cannabis company Jushi Inc.
    CNW Group4 months ago

    Cannabis Growth Opportunity Corporation announces investment in US based cannabis company Jushi Inc.

    Cannabis Growth Opportunity Corporation announces investment in US based cannabis company Jushi Inc.